Morphic Holding Stock Fundamentals
Morphic Holding fundamentals help investors to digest information that contributes to Morphic Holding's financial success or failures. It also enables traders to predict the movement of Morphic Stock. The fundamental analysis module provides a way to measure Morphic Holding's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Morphic Holding stock.
Morphic |
Morphic Holding Company Return On Asset Analysis
Morphic Holding's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Morphic Holding Return On Asset | -0.19 |
Most of Morphic Holding's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Morphic Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Morphic Holding has a Return On Asset of -0.1909. This is 97.82% lower than that of the Biotechnology sector and 99.19% lower than that of the Health Care industry. The return on asset for all United States stocks is 36.36% higher than that of the company.
Morphic Holding Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Morphic Holding's current stock value. Our valuation model uses many indicators to compare Morphic Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Morphic Holding competition to find correlations between indicators driving Morphic Holding's intrinsic value. More Info.Morphic Holding is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Morphic Holding by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Morphic Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Morphic Holding's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Morphic Holding could also be used in its relative valuation, which is a method of valuing Morphic Holding by comparing valuation metrics of similar companies.Morphic Holding is currently under evaluation in return on asset category among its peers.
Morphic Fundamentals
| Return On Equity | -0.27 | |||
| Return On Asset | -0.19 | |||
| Current Valuation | 2.24 B | |||
| Shares Outstanding | 50.22 M | |||
| Shares Owned By Insiders | 17.12 % | |||
| Shares Owned By Institutions | 91.02 % | |||
| Number Of Shares Shorted | 1.9 M | |||
| Price To Earning | (6.19) X | |||
| Price To Book | 4.63 X | |||
| Price To Sales | 2,753 X | |||
| Revenue | 521 K | |||
| Gross Profit | (31.25 M) | |||
| EBITDA | (177.59 M) | |||
| Net Income | (152.09 M) | |||
| Cash And Equivalents | 397.56 M | |||
| Cash Per Share | 10.33 X | |||
| Total Debt | 2.34 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 20.66 X | |||
| Book Value Per Share | 12.34 X | |||
| Cash Flow From Operations | (112.31 M) | |||
| Short Ratio | 0.37 X | |||
| Earnings Per Share | (3.83) X | |||
| Target Price | 56.13 | |||
| Number Of Employees | 128 | |||
| Beta | 1.49 | |||
| Market Capitalization | 2.86 B | |||
| Total Asset | 722.51 M | |||
| Retained Earnings | (449.19 M) | |||
| Working Capital | 692.15 M | |||
| Current Asset | 215.41 M | |||
| Current Liabilities | 32.65 M | |||
| Net Asset | 722.51 M |
About Morphic Holding Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Morphic Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Morphic Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Morphic Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts. Morphic Holding operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Morphic Stock
If you are still planning to invest in Morphic Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Morphic Holding's history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |